(Total Views: 152)
Posted On: 10/15/2024 12:12:07 PM
Post# of 25583

$BCTX No serious adverse events related to Bria-IMT™, 35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™, Pivotal Phase 3 study patient enrollment completion is expected in mid-2025
BIG NEWS https://feeds.issuerdirect.com/news-release.h...2967366263
BIG NEWS https://feeds.issuerdirect.com/news-release.h...2967366263

